ArticleFrontiers in medicine2025
Survival prediction modelling in patients with acute ST-segment elevation myocardial infarction with LASSO regression and explainable machine learning.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictive value of dynamic changes in RvD1, sST2, and PIV levels for the prognosis of STEMI patients after PCI: a prospective study.Frontiers in cardiovascular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute ST-segment elevation myocardial infarction (STEMI) is a cardiovascular emergency that is associated with a high risk of death. In this study, we developed explainable machine learning models to predict the overall survival (OS) of STEMI patients to help improve prognosis and increase survival. Methods: After applying the inclusion and exclusion criteria, we selected 893 patients who underwent emergency coronary angiography and percutaneous coronary intervention (PCI) for STEMI at the First Affiliated Hospital of Kunming Medical University. The best predictor variables were screened by least absolute shrinkage and selection operator (LASSO) regression. These variables were used to construct Cox proportional hazards regression (coxph) and random survival forest (rfsrc) models. Three criteria (C-index, Brier score, and C/D AUC) were utilised to compare the performance of the two models. Then, by applying the time-dependent variable importance and the partial dependence survival profile, a global explanation of the entire cohort was conducted. Finally, local explanations for individual patients were performed with the SurvSHAP(t) and SurvLIME plots and the ceteris paribus survival profile. Results: Combining the results of the comparison of the three criteria, the performance of the rfsrc model was shown to be superior to that of the coxph model. LASSO regression was used to screen 11 predictor variables, such as diastolic blood pressure (DBP), Killip class, hyperlipidaemia, global registry of acute coronary events (GRACE) Score, creatine kinase isoenzyme-MB, myoglobin, white blood cells, monocytes, thrombin time, globulin (GLB), and conjugated bilirubin. The global explanation of the whole cohort revealed that DBP, GRACE Score, myoglobin, and monocytes had a significant effect on the OS of STEMI patients in the coxph model and that DBP, GRACE Score, and GLB were the variables that significantly affected the OS of STEMI patients in the rfsrc model. Incorporating a single patient into the model can yield a local explanation of each patient, thus guiding clinicians in developing precision treatments. Conclusion: The rfsrc model outperformed the coxph model in terms of predictive performance. Clinicians can use these predictive models to understand the major risk factors for each STEMI patient and thus develop more individualised and precise treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.